US Stock MarketDetailed Quotes
CABA Cabaletta Bio
- 3.820
- +0.810+26.91%
Close Nov 29 13:00 ET
- 3.980
- +0.160+4.18%
Post 17:01 ET
186.71MMarket Cap-1768P/E (TTM)
4.600High3.610Low17.98MVolume3.800Open3.010Pre Close72.21MTurnover43.25%Turnover RatioLossP/E (Static)48.88MShares26.35052wk High1.07P/B158.78MFloat Cap1.76052wk Low--Dividend TTM41.57MShs Float26.350Historical High--Div YieldTTM32.89%Amplitude0.590Historical Low4.017Avg Price1Lot Size
About Cabaletta Bio Company
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Company Profile
SymbolCABA
Company NameCabaletta Bio
Listing DateOct 25, 2019
Issue Price11.00
Founded2017
CEODr. Steven Nichtberger,M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address2929 Arch Street,Suite 600
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-759-3100
Websitehttp://www.cabalettabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Steven Nichtberger,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 4.81M
- Anup Marda, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Arun Das, M.D.
- Chief Business Officer
- --
- David J. Chang, M.D.,M.P.H.
- Chief Medical Officer
- 2.10M
- Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
- President, Science and Technology
- 2.34M
- Shawn Cline Tomasello, M.B.A.
- Independent Director
- 509.94K
- Catherine Bollard, M.D.
- Independent Director
- 255.43K
- Mark Simon, M.B.A.
- Independent Director
- 260.15K
- Richard C. Henriques, M.B.A.
- Independent Director
- 259.20K
- Dr. Scott C. Brun, M.D.
- Independent Director
- 255.83K
- Michael Gerard, J.D.
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
